Sigilon Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Sigilon Therapeutics generated cash of -$51,474,000, which is more than the previous year. Cash used in financing activities reached the amount of -$1,606,000 last year. Net change in cash is therefore -$65,161,000.
Cash Flow
| 2018 | 38.33M | -1.65M | 24.22M |
|---|---|---|---|
| 2019 | -50.07M | -1.20M | 63.24M |
| 2020 | -61.64M | -972K | 189.39M |
| 2021 | -78.40M | -18.06M | 1.55M |
| 2022 | -51.47M | -12.08M | -1.60M |
SGTX Cash Flow Statement (2018 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Cash at beginning of period | 108.51M | 203.42M | 76.64M | 64.68M | 3.78M |
Operating activities | |||||
Net income | -43.56M | -77.31M | -54.60M | -43.92M | -22.76M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.26M | 1.11M | 854K | 675K | 374K |
Stock-based compensation expense | 5.90M | 6.14M | 3.12M | 2.07M | 821K |
| Deferred income tax benefit | 5.90M | 6.14M | 3.12M | 2.07M | 821K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -2.11M | 118K | -41K | -136K | 0 |
Inventories | 0 | -4.84M | 10.87M | 2.25M | 0 |
Accounts payable | -1.23M | 713K | -467K | 164K | 844K |
Cash generated by operating activities | -51.47M | -78.40M | -61.64M | -50.07M | 38.33M |
Investing activities | |||||
Purchases Of Investments | -42.52M | -16.22M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -537K | -1.83M | -972K | -1.20M | -1.65M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -12.08M | -18.06M | -972K | -1.20M | -1.65M |
Financing activities | |||||
Common Stock Issued | 61K | -622K | 132.52M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -622K | 51.72M | 0 | 0 |
Repayments of term debt | 0 | 0 | -15M | 0 | 0 |
Cash used in financing activities | -1.60M | 1.55M | 189.39M | 63.24M | 24.22M |
Net Change In Cash | -65.16M | -94.91M | 126.77M | 11.95M | 60.90M |
Cash at end of period | 43.35M | 108.51M | 203.42M | 76.64M | 64.68M |
| Data source | Data source | Data source |